1. Local therapy of cancer with free IL-2

   • Willem Den Otter
   • John J. L. Jacobs
   • Jan Willem Koten

   Position Paper Open access 07 February 2008 Pages: 931 - 950

   

2. Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions

   • Jennifer K. Mulligan
   • Deanne M. R. Lathers
   • M. Rita I. Young

   Original Article 04 December 2007 Pages: 951 - 961

   

3. CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients

   • Xiaorong Lin
   • Nancy H. Gudgeon
   • Anthony T. C. Chan

   Original Article 20 December 2007 Pages: 963 - 975

   

4. Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses

   • Richard Harrop
   • Noel Drury
   • Robert E. Hawkins

   Original Article 30 November 2007 Pages: 977 - 986

   

5. Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200

   • A. Siva
   • H. Xin
   • A. Kretz-Rommel

   Original Article 01 December 2007 Pages: 987 - 996

   

6. Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease

   • Tao Gu
   • Mehmet O. Kilinc
   • Nejat K. Egilmez

   Original Article 30 November 2007 Pages: 997 - 1005

   

7. RETRACTED ARTICLE: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF

   • Nobuto Yamamoto
   • Hirofumi Suyama
   • Yoshihiko Koga

   Original Article 06 December 2007 Pages: 1007 - 1016

   

8. A33 antigen displays persistent surface expression

   • Margaret E. Ackerman
   • Cecile Chalouni
   • K. Dane Wittrup

   Original Article 31 January 2008 Pages: 1017 - 1027

   

9. Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene

   • Li-Hua Xie
   • Fion Wan-Yee Sin
   • Yong Xie

   Original Article 22 December 2007 Pages: 1029 - 1038

   

10. Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma

    • P. Hersey
    • G. M. Halliday
    • S. W. Menzies

    Original Article 21 December 2007 Pages: 1039 - 1051

    

11. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)₂ fragment of anti-CD16 antibody

    • Anahid Jewett
    • Antonia Teruel
    • Nicholas Cacalano

    Original Article 10 January 2008 Pages: 1053 - 1066

    

12. In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1

    • Claudia Gravekamp
    • Belinda Leal
    • Robert Reddick

    Original Article 20 December 2007 Pages: 1067 - 1077

    

13. Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice

    • Assefa Wondimu
    • Tianqian Zhang
    • Dorothee Herlyn

    Original Article 22 December 2007 Pages: 1079 - 1089

    

14. Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression

    • Ya-Wen Hsiao
    • Kuang-Wen Liao
    • Rea-Min Chu

    Original Article 08 February 2008 Pages: 1091 - 1104